Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion type Assertion NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_head.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion description "[Because these data suggested that sensitivity of ESFTs to TRAIL was mainly based on the presence of DR4/DR5, we investigated the presence of these receptors in 32 ESFT tissue sections by immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_provenance.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion evidence source_evidence_literature NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_provenance.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion SIO_000772 11289151 NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_provenance.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion wasDerivedFrom befree-20140225 NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_provenance.
- NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_assertion wasGeneratedBy ECO_0000203 NP611731.RA6kQOek4PuRyCGCRLPgAGPxYWDKm6bXTgOF83R5LNReA130_provenance.